EXtended CriteriA treatment for LIver Metastases with heavy tumour BURde
Phase 1
- Conditions
- Patients with resectable colorectal liver metastasesTherapeutic area: Diseases [C] - Cancer [C04]
- Registration Number
- EUCTR2019-002388-87-NO
- Lead Sponsor
- Oslo University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 39
Inclusion Criteria
?Multiple colorectal liver metastases (8 or more metastases or 5 or more with marginal resectability)
?Progression on 1st line chemotherapy
?Primary tumour resected (for Excalibur 2 only)
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 20
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 19
Exclusion Criteria
?Extrahepatic disease
?Age > 70 years (for Excalibur 1 only)
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method